Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro

Pigment Cell Research

Volumn 17, Issue 6, 2004, Pages 636-642

  Chu, Shu Chen ^a   Hu, Dan Ning ^b,c   Yang, Shun Fa ^d   Yang, Pei Yuh ^b   Hsieh, Yih Shou ^d   Huang, Shen Min ^b   Yu, Guopei ^e   McCormick, Steven A ^c  

^a CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^b SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

12 O tetradecanoyl phorbol 13 acetate; Gelatin zymography; In vitro; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Uveal melanocytes

Indexed keywords

COMPLEMENTARY DNA; GELATIN; GELATINASE A; GELATINASE B; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CHOROID; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IRIS; MELANOCYTE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UVEA; UVEA MELANOMA; VITREORETINOPATHY; ZYMOGRAPHY;

CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; UVEA;

EID: 9244255247     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2004.00181.x     Document Type: Article

References (49)

1. Bode W, Fernandez-Catalan C, Tschesche H, Grams F, Nagase F, Maskos K. Structural properties of matrix metalloproteinases. Cell Mol Life Sci 1999;55:639-652
2. Kugler A. Matrix metalloproteinases and their inhibitors. Anticancer Res 1999;19:1589-1592
3. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494
4. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904
5. Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, Klebe RJ. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 1998;16:483-496
6. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998;21:75-80
7. Cuzner L, Opdenakker G. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 1999;94:1-14
8. Kaehaeri VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors on tumour growth and invasion. Ann Med 1999;31:34-45
9. Alexander JP, Samples JR. Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 2001;32:172-180
10. Fini ME. Girard MT, Matsubara M, Bartlett JD. Unique regulation of the matrix metalloproteinase, gelatinase B. Invest Ophthalmol Vis Sci 1995;36:622-633
11. Guggenheim JA, McBrien NA. Form-deprivation myopia induces activation of scl eral matrix metalloproteinases-2 in tree shrew. Invest Ophthalmol Vis Sci 1996;37:1380-1395
12. Immonen I, Konttinen YT, Sorsa T, Tommila P, Siren V. Proteinases in subretinal fluid. Graefes Arch Clin Exp Ophthalmol 1996;234:105-109
13. Di Girolamo N, Lioyd A, McCluskey P, Filipic M, Wakefield D. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 1997;150:653-666
14. Rada JA, Perry CA, Solver ML, Ashen VR. Gelatinase and TIMP-2 expression in the fibrous sciera of myopic and recovering chicken eyes. Invest Ophthalmol Vis Sci 1999;40:3091-3099
15. Alexander JP, Acott TS. Involvement of protein kinase C in TNF alpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci 2001;42:2831-2838
16. El-Shabrawi Y, Ardjomand N, Radner H, Ardjomand N. MMP-9 is predominantly expressed in epitheloid and not spindle cell uveal melanoma. J Pathol 2001;94:201-206
17. Gaton DD, Sagara T, Linsey JD, Gabelt BT, Kaufman PL, Weinreb RN. Increased matrix metalloproteinase 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F (2 alpha) - isopropyl ester treatment. Arch Ophthalmol 2001;119:1165-1170
18. Kim JW, Lindsey JD, Wang N, Weinreb RN. Increased human scierai permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci 2001;42:1514-1521
19. Eichler W, Friedrichs U, Thies A, Tratz C, Wiedemann P. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest Ophthalmol Vis Sci 2002;43:2767-2773
20. Edwin SS, Romero R, Rathnasabapathy CM, Athaydel N, Armant DR, Subramanian MG. Protein kinase C stimulates release of matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 by human decidual cells. J Matern Fetal Neonatal Med 2002;12:231-236
21. Smine A, Plantner JJ. Membrane type-1 matrix metalloproteinase in human ocular tissues. Curr Eye Res 1997;16:925-929
22. Guo L, Hussain AA, Limb GA, Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest Ophthalmol Vis Sci 1999;40:2676-2682
23. Kvanta A, Shen WY, Sarman S, Seregard S, Steen B, Rakoczy E. Matrix metalloproteinases (MMP) expression in experimental choroidal neovascularization. Curr Eye Res 2000;21:684-690
24. Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO. Drusen are cold spots for proteolysis: expression of matrix metalloproteinases and their tissue inhibitor proteins in age-related macular degeneration. Exp Eye Res 2002;74:141-154
25. Beliveau AS, Beruhe M, Rousseau A, Pelletier G, Guerin SL. Expression of intergrin α5βl and MMPs associated with epitheloid morphology and malignancy of uveal melanoma. Invest Ophthalmol Vis Sci 2000;41:2363-2372
26. Hu DN, McCormick SA, Ritch R, Pelton-Henrion K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci 1993;33:2210-2219
27. Hu DN, McCormick SA, Orlow SJ, Rosemblat S, Lin AY, Wo K. Melanogenesis in cultured human uveal melanocytes. Invest Ophthalmol Vis Sci 1995;36:931-938
28. Hu DN. Regulation of growth and melanogenesis of uveal melanocytes. Pigment Cell Res 2000;13 (Suppl. 8):81-86
29. Chang YC, Yang SF, Hsieh YS. Regulation of matrix metalloproteinase-2 production by cytokines and pharmacological agents on human pulp cell cultures. J Endo 2001;27:679-682
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159
31. Romanic AM, Madri JA. Extracellular matrix-degrading proteinase in the nervous system. Brain Pathol 1994;4:145-156
32. Aimes RT, Quigley JP. Matrix metalloproteinases is an interstitial collagenase. J Biol Chem 1995;270:5872-5876
33. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M. Localization of matrix metalloproteinases-9 (92 kDa gelatinase/type IV collagenase gelatinase B) in osteoclasts; implications for bone resorption. Lab Invest 1995;72:311-322
34. Murphy G, Stanton H, Cowell S, Butler G, Knaeuper V, Atkinson S, Gavrilovic J. Mechanisms for pro matrix metalloproteinases activation. APMIS 1999;107:38-44
35. Seiki M. Membrane-type matrix metalloproteinases. APMIS 1999;107:137-143
36. Hu DN, McCormick SA, Ritch R. Studies of human uveal melanocytes in vitro: Growth regulation of cultured human uveal melanocytes. Invest Ophthalmol Vis Sci 1993;34:2220-2227
37. Hu DN, McCormick SA, Orlow SJ, Rosemblat S, Lin AY. Regulation of melanogenesis by human uveal melanocytes in vitro. Exp Eye Res 1997;64:397-404
38. Hu DN, McCormick SA, Lin AY, Lin JY. TGF-β2 inhibits growth of uveal melanocytes at physiological concentrations. Exp Eye Res 1998;67:143-150
39. 2α, and latanoprost on cultured human iridal melanocytes. Exp Eye Res 2000;70:113-120
40. Hu DN, McCormick SA, Woodward DF. A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation. Exp Eye Res 2001;73:93-100
41. Hu DN, Savage H, Roberts JE. Uveal melanocytes, ocular pigment epithelium and Mueller cells in culture: in vitro toxicology. Inter J Toxicol 2002;21:465-472
42. Wang Y, Hu DN, McCormick SA, Savage HE, O'Rourke J. Tissue plasminogen activator is released into cultured medium by cultured human uveal melanocytes. Pigment Cell Res 2002;15:373-378
43. Hu DN, Woodward DF, McCormick SA. Influence of autonomic neurotransmitters on human uveal melanocytes in vitro. Exp Eye Res 2000;71:217-224
44. Cahndraskar N, Jast S, Alfred-Yung WK, Ali-Osman F, Dinh DH, Olivero WC, Gujrati M, Kyritsis AP, Nicolson GL, Rao JS, Mohanam S. Modulation of endothelial morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions. Clin Exp Metastasis 2000;18:337-342
45. Shearer T, Crosson CE. Activation of extracellular signal-regulated kinase in trabecular meshwork cells. Exp Eye Res 2001;73:25-35
46. Lee WJ, Shih CY, Yoo BK, Ryu JR, Choi EY, Cheong JH, Ryu JH, Ko KH. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary asctrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk 1/2). Glia 2003;41:15-24
47. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells: effects of tumor necrosis factor alpha, interleukin 1 and phobol ester. Biochem J 1993;296 (Pt 3):803-809
48. Murphy TL, Sakamoto T, Hinton DR, Spee C, Gundimeda U, Soriano D, Gopalakrishna R, Ryan SJ. Migration of retinal pigment epithelium cells in vitro is regulated by protein kinase C. Exp Eye Res 1995;60:683-695
49. Weinstein IB, Kahn SM, O'Driscoll K, Borner C, Bang D, Jiang W, Blackwood A, Nomoto K. The role of protein kinase C in signal transduction, growth control and lipid metabolism. Adv Exp Med Biol 1997:400A:313-321